Advanced search
Publication Cover
Acta Oncologica Volume 31, 1992 - Issue 4
Journal homepage
116
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Droloxifene—A New Anti-Estrogen; A phase II study in advanced breast cancer

Helce Haarstad Dept. of Oncology, University Hospital of Trondheim, Trondheim
,
Stein Gundersen The Norwegian Radium Hospital, Oslo
,
Erik Wist University Hospital of Tromse, Tromso
,
Nils Raabe Ullevil Hospital, Oslo
,
Olav Mella Haukeland Hospital, Bergen
&
Stener Kvinnsland The Norwegian Radium Hospital, Oslo
Pages 425-428 | Received 10 Jul 1991, Accepted 13 Nov 1991, Published online: 08 Jul 2009

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Stephen Martinkovich, Darshan Shah, Sonia Lobo Planey & John A Arnott. (2014) Selective estrogen receptor modulators: tissue specificity and clinical utility. Clinical Interventions in Aging 9, pages 1437-1452.
Read now

Articles from other publishers (21)

A. Jameera Begam, S. Jubie & M.J. Nanjan. (2017) Estrogen receptor agonists/antagonists in breast cancer therapy: A critical review. Bioorganic Chemistry 71, pages 257-274.
Crossref
Ruth M. O’Regan & William J. Gradishar. 2002. Hormone Therapy in Breast and Prostate Cancer. Hormone Therapy in Breast and Prostate Cancer 195 212 .
Tatjana El??ne Vogelvang, Marius Jan van der Mooren, Velja Mijatovic & Peter Kenemans. (2006) Emerging Selective Estrogen Receptor Modulators. Drugs 66:2, pages 191-221.
Crossref
J.F.R. Robertson, S.E. Come, S.E. Jones, L. Beex, M. Kaufmann, A. Makris, J.W.R. Nortier, K. Possinger & L.-E. Rutqvist. (2005) Endocrine treatment options for advanced breast cancer – the role of fulvestrant. European Journal of Cancer 41:3, pages 346-356.
Crossref
John F.R. Robertson. (2004) Selective oestrogen receptor modulators/new antioestrogens: a clinical perspective. Cancer Treatment Reviews 30:8, pages 695-706.
Crossref
Steven R. Deitcher & Marcelo P. V. Gomes. (2004) The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma. Cancer 101:3, pages 439-449.
Crossref
Sacha J Howell, Stephen R.D Johnston & Anthony Howell. (2004) The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancer. Best Practice & Research Clinical Endocrinology & Metabolism 18:1, pages 47-66.
Crossref
Irene Boeddinghaus & Mitch Dowsett. 2002. Breast Cancer. Breast Cancer 343 371 .
A. Buzdar, D. Hayes, A. El-Khoudary, S. Yan, P. Lønning, M. Lichinitser, R. Gopal, G. Falkson, K. Pritchard, A. Lipton, K. Wolter, A. Lee, K. Fly, R. Chew, M. Alderdice, K. Burke & P. Eisenberg. (2002) Phase III Randomized Trial of Droloxifene and Tamoxifen As First-Line Endocrine Treatment of ER/PgR-Positive Advanced Breast Cancer. Breast Cancer Research and Treatment 73:2, pages 161-175.
Crossref
E.A. Lien & P.E. Lønning. (2000) Selective oestrogen receptor modifiers (SERMs) and breast cancer therapy. Cancer Treatment Reviews 26:3, pages 205-227.
Crossref
Anthony Howell. (2000) Tamoxifen versus the newer SERMs: what is the evidence?. Annals of Oncology 11, pages 255-266.
Crossref
Nuhad K Ibrahim & Gabriel N Hortobagyi. (1999) The evolving role of specific estrogen receptor modulators (SERMs). Surgical Oncology 8:2, pages 103-123.
Crossref
Felicia Cosman & Robert Lindsay. (1999) Selective Estrogen Receptor Modulators: Clinical Spectrum*. Endocrine Reviews 20:3, pages 418-434.
Crossref
Susan E. Minton. (2017) New Hormonal Therapies for Breast Cancer. Cancer Control 6:3, pages 247-255.
Crossref
William J. Gradishar & V. Craig Jordan. 1999. Endocrinology of Breast Cancer. Endocrinology of Breast Cancer 283 311 .
Nuhad K. Ibrahim & Gabriel N. Hortobagyi. (1998) New Antiestrogens in Breast Cancer: A Review. The Breast Journal 4:4, pages 213-229.
Crossref
Gretchen G. Kimmick & Hyman B. Muss. 1998. Biological and Hormonal Therapies of Cancer. Biological and Hormonal Therapies of Cancer 231 254 .
V.Craig Jordan & William J. Gradishar. (1997) Molecular mechanisms and future uses of antiestrogens. Molecular Aspects of Medicine 18:3, pages 167-247.
Crossref
A. Howell, S. Downey & E. Anderson. (1996) New endocrine therapies for breast cancer. European Journal of Cancer 32:4, pages 576-588.
Crossref
Jacqueline Dalski & Max Görlich. (2018) Steroid Hormone Levels in Patients with Advanced Breast Cancer during Therapy with Droloxifene: A Pilot Study. Tumori Journal 82:1, pages 45-47.
Crossref
Karmen Wong & I. Craig Henderson. (1994) Management of metastatic breast cancer. World Journal of Surgery 18:1, pages 98-111.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.